EGFR and lung adenocarcinoma: As shown in Table 3, for the patients of Asian descent with grade I and II lung adenocarcinoma, the incidence of EGFR mutations was 60.9%, compared to 26.9% for the patients of Asian descent with grade II–III and III histology, a more than two-fold difference (p = 0.006).